Caricamento...
One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
BACKGROUND: Ataluren was approved for the treatment of nmDMD, both the efficacy and safety have been previously reported only from clinical trials but no report exists about real-life experience. PATIENT/METHODS: we describe three Italian children with nmDMD treated with ataluren for 1 year. Measure...
Salvato in:
| Pubblicato in: | Ther Adv Neurol Disord |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236582/ https://ncbi.nlm.nih.gov/pubmed/30542376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418809588 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|